BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29369007)

  • 21. [Polydatin induces human cervical cancer cell apoptosis via PI3K/AKT/mTOR signaling pathway].
    Pan JH; Wang HB; Du XF; Liu JY; Zhang DJ
    Zhongguo Zhong Yao Za Zhi; 2017 Jun; 42(12):2345-2349. PubMed ID: 28822191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual inhibition of the PI3K/AKT/mTOR pathway suppresses the growth of leiomyosarcomas but leads to ERK activation through mTORC2: biological and clinical implications.
    Fourneaux B; Chaire V; Lucchesi C; Karanian M; Pineau R; Laroche-Clary A; Italiano A
    Oncotarget; 2017 Jan; 8(5):7878-7890. PubMed ID: 28002802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pterostilbene (3',5'-dimethoxy-resveratrol) exerts potent antitumor effects in HeLa human cervical cancer cells via disruption of mitochondrial membrane potential, apoptosis induction and targeting m-TOR/PI3K/Akt signalling pathway.
    Hong Bin W; Da LH; Xue Y; Jing B
    J BUON; 2018; 23(5):1384-1389. PubMed ID: 30570862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comparison between dual inhibition of mTOR with MAPK and PI3K signaling pathways in KRAS mutant NSCLC cell lines.
    Dogan Turacli I; Ozkan AC; Ekmekci A
    Tumour Biol; 2015 Dec; 36(12):9339-45. PubMed ID: 26108998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extract from Astragalus membranaceus inhibit breast cancer cells proliferation via PI3K/AKT/mTOR signaling pathway.
    Zhou R; Chen H; Chen J; Chen X; Wen Y; Xu L
    BMC Complement Altern Med; 2018 Mar; 18(1):83. PubMed ID: 29523109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer.
    Liu JJ; Ho JY; Lee HW; Baik MW; Kim O; Choi YJ; Hur SY
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer.
    Huang S; Wang D; Zhang S; Huang X; Wang D; Ijaz M; Shi Y
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):685-696. PubMed ID: 28779263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effects of antibiotic drug mefloquine against cervical cancer through impairing mitochondrial function and inhibiting mTOR pathway.
    Li H; Jiao S; Li X; Banu H; Hamal S; Wang X
    Can J Physiol Pharmacol; 2017 Jan; 95(1):43-50. PubMed ID: 27831748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
    Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
    Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BF12, a Novel Benzofuran, Exhibits Antitumor Activity by Inhibiting Microtubules and the PI3K/Akt/mTOR Signaling Pathway in Human Cervical Cancer Cells.
    Gao Y; Ma C; Feng X; Liu Y; Haimiti X
    Chem Biodivers; 2020 Mar; 17(3):e1900622. PubMed ID: 31951313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of miR-214 on cervical cancer cell proliferation, apoptosis and invasion via modulating PI3K/AKT/mTOR signal pathway.
    Wang F; Tan WH; Liu W; Jin YX; Dong DD; Zhao XJ; Liu Q
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1891-1898. PubMed ID: 29687840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
    Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW
    Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting mTOR by CZ415 Suppresses Cell Proliferation and Promotes Apoptosis via Lipin-1 in Cervical Cancer In Vitro and In Vivo.
    Zhang J
    Reprod Sci; 2021 Feb; 28(2):524-531. PubMed ID: 32944878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Synergistic Antitumor Effect of Everolimus Combined with Gemcitabine on Diffuse Large B-Cell Lymphoma].
    Zuo XQ; Tan CL; Li XM; Ma T
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):81-88. PubMed ID: 36765481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
    Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
    Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
    Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
    Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y; Chen X; Luo Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):592-6. PubMed ID: 24909280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic in vitro anti-tumor effect of letrozole and everolimus on human endometrial carcinoma Ishikawa cells.
    Lu XY; Yang Y; Xu H; Zeng T; Zhang ZZ
    Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2264-9. PubMed ID: 25219824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways.
    Wu Y; Dong L; Bao S; Wang M; Yun Y; Zhu R
    Biomed Pharmacother; 2016 Dec; 84():462-469. PubMed ID: 27685789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.